Covered recipient · General Payments record
HARISH GUDDATI
General Payments · PY2019–2024
$1,450.32
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $424.73 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $227.38 | 11 |
| Takeda Pharmaceuticals U.S.A., Inc. | $114.22 | 4 |
| Celgene Corporation | $31.58 | 2 |
| Celltrion USA Inc. | $28.88 | 1 |
| Lilly USA, LLC | $22.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.74 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846374 | CMS |
| ABBVIE INC. | $16.13 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846376 | CMS |
| ABBVIE INC. | $26.33 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846378 | CMS |
| ABBVIE INC. | $21.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846380 | CMS |
| ABBVIE INC. | $2.32 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846382 | CMS |
| ABBVIE INC. | $28.71 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846384 | CMS |
| ABBVIE INC. | $25.89 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846386 | CMS |
| ABBVIE INC. | $23.62 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846388 | CMS |
| ABBVIE INC. | $0.78 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846390 | CMS |
| ABBVIE INC. | $30.21 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846392 | CMS |
| ABBVIE INC. | $23.65 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103846394 | CMS |
| Celgene Corporation | $14.72 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101155306 | CMS |
| Celgene Corporation | $16.86 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101155312 | CMS |
| Celltrion USA Inc. | $28.88 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075851877 | CMS |
| Lilly USA, LLC | $22.67 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135020124 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.17 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137564428 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.04 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137564432 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.25 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137564436 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.76 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137564440 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.